| Hepatitis B virus pregenomic RNA is present in virions in plasma and is associated with a response to pegylated interferon alfa-2a and nucleos (t) ide analogues L Jansen, NA Kootstra, KA van Dort, RB Takkenberg, HW Reesink, ... The Journal of infectious diseases 213 (2), 224-232, 2016 | 176 | 2016 |
| PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma K Sideras, K Biermann, J Verheij, BR Takkenberg, S Mancham, ... Oncoimmunology 6 (2), e1273309, 2017 | 137 | 2017 |
| Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma: a response‐based approach G Han, S Berhane, H Toyoda, D Bettinger, O Elshaarawy, AWH Chan, ... Hepatology 72 (1), 198-212, 2020 | 107 | 2020 |
| Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir RB Takkenberg, L Jansen, A De Niet, HL Zaaijer, CJ Weegink, V Terpstra, ... Antiviral therapy 18 (7), 895-904, 2013 | 104 | 2013 |
| Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study L Wieske, KPJ van Dam, M Steenhuis, EW Stalman, LYL Kummer, ... The Lancet Rheumatology 4 (5), e338-e350, 2022 | 103 | 2022 |
| Evaluating the endoscopic reference score for eosinophilic esophagitis: moderate to substantial intra-and interobserver reliability BD van Rhijn, MJ Warners, WL Curvers, AU van Lent, NL Bekkali, ... Endoscopy 46 (12), 1049-1055, 2014 | 94 | 2014 |
| Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial A de Niet, L Jansen, F Stelma, SB Willemse, SD Kuiken, S Weijer, ... The lancet Gastroenterology & hepatology 2 (8), 576-584, 2017 | 59 | 2017 |
| TIGIT and PD1 co-blockade restores ex vivo functions of human tumor-infiltrating CD8+ T cells in hepatocellular carcinoma Z Ge, G Zhou, LC Carrascosa, E Gausvik, PPC Boor, L Noordam, ... Cellular and Molecular Gastroenterology and Hepatology 12 (2), 443-464, 2021 | 56 | 2021 |
| Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha‐2a and adefovir B Takkenberg, V Terpstra, H Zaaijer, C Weegink, M Dijkgraaf, P Jansen, ... Journal of gastroenterology and hepatology 26 (10), 1527-1535, 2011 | 56 | 2011 |
| Ursodeoxycholic acid in advanced polycystic liver disease: a phase 2 multicenter randomized controlled trial HMA D’Agnolo, W Kievit, RB Takkenberg, I Riaño, L Bujanda, ... Journal of hepatology 65 (3), 601-607, 2016 | 54 | 2016 |
| Plasma microRNA levels are associated with hepatitis B e antigen status and treatment response in chronic hepatitis B patients MH Van Der Ree, L Jansen, Z Kruize, AC Van Nuenen, KA Van Dort, ... The Journal of Infectious Diseases 215 (9), 1421-1429, 2017 | 52 | 2017 |
| Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy A de Niet, F Stelma, L Jansen, MJ Sinnige, EBM Remmerswaal, ... Journal of Hepatology 64 (3), 539-546, 2016 | 51 | 2016 |
| Breakthrough SARS-CoV-2 infections with the delta (B. 1.617. 2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy … L Boekel, EW Stalman, L Wieske, F Hooijberg, KPJ van Dam, YR Besten, ... The Lancet Rheumatology 4 (6), e417-e429, 2022 | 49 | 2022 |
| Natural killer cell characteristics in patients with chronic hepatitis B virus (HBV) infection are associated with HBV surface antigen clearance after combination treatment … F Stelma, A de Niet, MJ Tempelmans Plat-Sinnige, L Jansen, ... The Journal of infectious diseases 212 (7), 1042-1051, 2015 | 48 | 2015 |
| Genetic variation in IL28B and treatment outcome in HBeAg-positive and-negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir A De Niet, RB Takkenberg, R Benayed, B Riley-Gillis, CJ Weegink, ... Scandinavian journal of gastroenterology 47 (4), 475-481, 2012 | 47 | 2012 |
| Validation of a sensitive and specific real‐time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients RB Takkenberg, HL Zaaijer, R Molenkamp, S Menting, V Terpstra, ... Journal of medical virology 81 (6), 988-995, 2009 | 46 | 2009 |
| Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels K Sideras, RA de Man, SM Harrington, WG Polak, G Zhou, HM Schutz, ... Scientific reports 9 (1), 10677, 2019 | 44 | 2019 |
| Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma EM Noorda, B Takkenberg, BC Vrouenraets, OE Nieweg, BN van Geel, ... Annals of Surgical Oncology 11, 491-499, 2004 | 40 | 2004 |
| New developments in antiviral therapy for chronic hepatitis B RB Takkenberg, CJ Weegink, HL Zaaijer, HW Reesink Vox sanguinis 98 (4), 481-494, 2010 | 35 | 2010 |
| Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study RC Oey, K de Wit, A Moelker, T Atalik, OM van Delden, G Maleux, ... Alimentary pharmacology & therapeutics 48 (9), 975-983, 2018 | 33 | 2018 |
HW ReesinkVerified email at amc.nl
